Three-year clinical results from the TAXUS V de novo trial:: Longterm safety and efficacy of the paclitaxel-eluting TAXUS stent in complex lesions

被引：0
|
作者：
Ellis, Stephen G. [1 ]
Cannon, Louis A. [2 ]
Mann, Tiff [3 ]
Greenberg, Joel D. [4 ]
Cambier, Patrick A. [5 ]
O'Shaughnessy, Charles D. [6 ]
DeMaio, Samuel [7 ]
Hall, Patrick [8 ]
Powers, Eric [9 ]
Friedman, Mark [10 ]
Stone, Gregg W. [11 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] Cardiac & Vasc Ctr No Michigan, Petoskey, OH USA
[3] WakeMed, Raleigh, NC USA
[4] Florida Hosp, Orlando, FL USA
[5] Heart & Vasc Inst Florida, Clearwater, FL USA
[6] Elyria Mem Hosp, Elyria, OH USA
[7] S Austin Hosp, Austin, TX USA
[8] Sisters Char Providence Hosp, Columbia, SC USA
[9] Univ Virginia Cardiol, Charlottesville, VA USA
[10] Boston Sci Corp, Marlborough, MA USA
[11] Columbia Univ, Med Ctr, New York, NY 10027 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2007年 / 100卷 / 8A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：35L / 35L
页数：1
相关论文
共 50 条
  • [41] A Randomized Multicenter Comparison of the CRE8 coronary stent with the TAXUS Liberte Paclitaxel-Eluting stent in De Novo native coronary artery lesions
    Carrie, Didier
    Schofer, Joachim
    Berland, Jacques
    Verheye, Stefan
    Hauptmann, Karl Eugen
    Vrolix, Mathias
    Violini, Roberto
    Berti, Sergio
    Dibie, Alain
    Maupas, Eric
    Antoniucci, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : XIV - XIV
  • [42] TAXUS II 3-year clinical results: Durability of the benefit of polymer-based, paclitaxel-eluting stents in the treatment of de novo coronary artery lesions
    Colombo, A
    Banning, A
    Silber, S
    Hauptmann, KE
    Drzewiecki, J
    Grube, E
    Wijatyk, A
    Russell, ME
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 129H - 130H
  • [43] A RANDOMIZED COMPARISON OF THE ENDEAVOR DRUG (ABT-578) ELUTING STENT VERSUS TAXUS PACLITAXEL-ELUTING STENT IN DIABETIC PATIENTS: THREE-YEAR OUTCOMES FROM ENDEAVOR IV
    Kirtane, Ajay
    Patel, Rikesh
    O'Shaunessy, Charles
    McLaurin, Brent
    Kandzari, David E.
    Leon, Martin B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [44] Outcomes After Implantation of the TAXUS Paclitaxel-Eluting Stent in Saphenous Vein Graft Lesions Results From the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) Program
    Brilakis, Emmanouil S.
    Lasala, John M.
    Cox, David A.
    Berger, Peter B.
    Bowman, Thomas S.
    Starzyk, Ruth M.
    Dawkins, Keith D.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (07) : 742 - 750
  • [45] Geographical differences in 9-month clinical and angiographic outcomes after TAXUS Liberte paclitaxel-eluting stent implantation in the TAXUS ATLAS trial
    Ormiston, John A.
    Turco, Mark A.
    Wu, Chiung-Jen
    D O'Shoughnessy, Charles
    Chan, Charles
    Webster, Mark W. I.
    McGarry, Thomas F.
    Popma, Jeffry J.
    Mandinov, Lazar
    Koglin, Joerg
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 145M - 146M
  • [46] Paclitaxel-eluting stent in patients with acute coronary syndromes: Analysis from the TAXUS-IV trial
    Moses, JW
    Mehran, R
    Nikolsky, E
    Lasala, JM
    Corey, W
    Albin, G
    Hirsch, C
    Leon, MB
    Russell, ME
    Ellis, SG
    Na, Y
    Stone, GW
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 72E - 73E
  • [47] Comparison of efficacy and safety between Sirolimus-eluting stent (Cypher) and Paclitaxel-eluting stent (TAXUS) on the outcome of patients with diffuse in-stent restenosis
    Nakamura, S.
    Bae, J. H.
    Cahyadi, Y. H.
    Udayachalerm, W.
    Tresukosol, D.
    Tansuphaswadikul, S.
    EUROPEAN HEART JOURNAL, 2006, 27 : 654 - 654
  • [48] Comparison of efficacy and safety between sirolimus-eluting stent (Cypher) and paclitaxel-eluting stent (TAXUS) on the outcome of patients with diffuse in-stent restenosis
    Nakamura, S.
    Muthusamy, T. S.
    Bae, J. H.
    Cahyadi, Y. H.
    Udayachalerm, W.
    Tresukosol, D.
    Tansuphaswadikul, S.
    EUROPEAN HEART JOURNAL, 2005, 26 : 468 - 468
  • [49] Comparison of efficacy and safety between sirolimus-eluting stent (Cypher™) and paclitaxel-eluting stent (TAXUS™) on the outcome of patients with diffuse in-stent restenosis
    Nakamura, S
    Bae, JH
    Cahyadi, YH
    Udayachalerm, W
    Tresukosol, D
    Tansuphaswadikul, S
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 96H - 96H
  • [50] Long-Term Safety and Clinical Efficacy Outcomes of the Paclitaxel-Eluting Stent from a Patient-Level Pooled Analysis of the TAXUS Clinical Trials
    Stone, Gregg W.
    Colombo, Antonio
    Grube, Eberhard
    Uchida, Takahiro
    Dawkins, Keith D.
    Baim, Donald S.
    Ellis, Stephen G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 15D - 16D
12345